Twenty-nine day study of stability for six different parenteral nutrition mixtures by unknown
Available online http://ccforum.com/content/1/1/41http://ccforum.com/content/1/1/41Research
Twenty-nine day study of stability for six different parenteral 
nutrition mixtures
Jean-Claude Desport1,2, Brigitte Hoedt3, Véronique Pelagatti1, Aline Lagarde1, Françoise Lorieul4, 
Danièle Chalmel4, Fabrice Sultan4 and Pierre Feiss4
1Département d'Anesthésie Réanimation Chirugicale, CHU Dupuytren, 87042 Limoges Cedex, France.
2Unité Fonctionnelle de Nutrition, CHU Dupuytren, 87042 Limoges Cedex, France.
3Pharmacie Centrale, CHU Dupuytren, 87042 Limoges Cedex, France.
4Laboratoires B Braun Médical SA, Avenue du Maréchal Juin, 92107 Boulogne Cedex, France.
Background: The aim of the study was to assess the particle size stability of six parenteral nutrition
regimens, fitted to various pathologies, and used by the University Hospital of Limoges. The mixtures
contained glucose (30 or 50%), amino acids (Hyperamine®25), and either long-chain triglycerides
(20% Intralipide®) or a combination of medium and long-chain triglycerides (20% Médialipide®). The
regimens were not supplemented.
Results: The visual examinations, particle size analysis and physico-chemical tests, carried out during
a long storage period, did not reveal any significant evolution of the lipid emulsions. All the tested
formulae were stable for 28 days at 4°C plus 24 h at room temperature.
Conclusions: It was concluded that the choice of lipid emulsions depends, for these formulae, on the
metabolic and clinical needs of the treated patients.
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Introduction
Parenteral nutrition is often peri-operative. It can be per-
formed with packages containing different nutrients.
Knowledge of the stability of these mixtures is necessary,
because the infusion of unstable compounds is potentially
dangerous [1]. Since Fujita's animal studies in 1971, it has
been accepted that there is a relationship between toxicity
and particle size [2]. The predominant factors affecting
emulsion particle size seem to be pH, electrolyte concen-
tration, and the amino acid and lipid composition of the mix-
tures [3,4]. A reduced stability is indicated by a low zeta
potential, which is a standard parameter used to measure
the electrostatic repulsion which prevents aggregation and
coalescence of lipid droplets [4,5]. The aim of this study
was to test the particle size stability of six parenteral nutri-
tion mixtures fitted to different pathologies (Table 1). The
mixtures tested were standard packages, with and without
medium chain triglycerides (MCT); packages of low volume
for renal or cardiac insufficiency, with and without MCT;
packages with low lipid, high protein content with MCT, for
mechanical ventilation weaning or stress situations; and
high calorie, high protein mixtures with MCT, for situations
with high requirements. All the tested formulae were stable
for 28 days at 4°C plus 24 h at room temperature.
Material and methods
The mixtures were not supplemented by electrolytes, trace
elements or vitamins. The packages, made of ethylene vinyl
acetate (EVA) (Nutripoches NPP235: Pharmacia SA,
France), contained 50 or 30% glucose (Aguettant and
Cooper Laboratories, St Quentin, France), amino acids
15.28 g/100 ml (Hyperamine 25®, B Braun Médical SA,
France), and 20% lipids consisting of either medium and
long-chain triglycerides (Médialipide®, B Braun Médical
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Pharmaica, France) (Table 1). The Central Pharmacy of the
hospital filled the packages under nitrogen pressure in a
clean room inside a laminary horizontal flux hood. Glucose
was introduced first into each mixture bag, followed by the
amino acids and finally the lipids. Two packages (one ana-
lytical and one observation bag for each regimen) were for-
warded by air freight in a cold box to the stability control
laboratory (B Braun Médical SA, Boulogne, France) within
24 h of production. They were stored in a refrigerator at 4
± 1° C (circulating air) for 28 days, then for 24 h at room
temperature. At the end of this period, each mixture was
compared with the corresponding mother emulsion, which
contained only lipids from the same batch. The stability
tests were performed according to the following methods.
Visual observation
The colour and aspect of the mixtures was noted, with each
being examined for creaming, oily droplets and the pres-
ence or absence of yellow traces. These examinations were
performed without shaking the mixtures, and were carried
out on the observation bags throughout the entire study. In
the analytical bags, they were performed at each stage of
analysis before and after the homogenization of the mix-
tures, which was done by inverting the bags 10 times
according to the common conditions of use.
Visual microscopic observations
Visual microscopic observations (Leitz-Diaplan micro-
scope) calculated the number of droplets with diameter >
2.5 µm. The dilution of the emulsions was 1:10 in order to
obtain a final lipid concentration of 2 g/100 ml. The obser-
vations were made in a cell counting chamber (Thoma's
grads) at × 500 magnification. A significant increase in par-
ticles with diameter > 5 µm indicated destabilisation and
the presence of particles with diameter > 10 µm revealed a
breakdown of the emulsion [1]. Polaroid microphotography
(× 1000 magnification) confirmed the observations.
Particle size analysis
Particle size analysis was performed with a Coulter Counter
TA II, with a 50 µm aperture. The results were expressed in
terms of percentage of fat (% of total lipidic fraction) exist-
ing as particles in each different diameter class studied.
This calculation took into account the number and mean
diameter of particles in each class, the fat concentration of
Table 1
Contents, distinctive composition and suggested indications of the six tested parenteral nutrition mixtures
Formulae
Composition 1 2 3 4 5 6
50% Glucose (ml) 500 500 650 600
30% Glucose (ml) 750 750
20% Intralipide® (ml) 500 500
20% Médialipide® (ml) 500 500 500 600
Hyperamine® 25 (ml) 500 500 500 500 750 750
Total volume (ml) 1750 1750 1500 1500 1900 1950
Nitrogen (g) 12.8 12.8 12.8 12.8 19.2 19.2
Glucido-lipidic ratio (% : %) 47 : 53 48 : 52 50 : 50 50 : 50 57 : 43 50 : 50
kcal/Nitrogen ratio 148 147 156 155 119 124
Glucido-lipidic kcal 1900 1884 2000 1984 2284 2381
Distinctive composition Standard Standard with 
MCT
Low volume Low volume with 
MCT
Low lipid, high protein 
content, with MCT
High kcal, high protein 
content with MCT
Suggested indications Standard Standard Cardiac or renal 
insufficiency





MCT=medium chain triglycerides. Médialipide® is a registered trademark (in Germany, Lipofundin® MCT/LCT; in Denmark, Norway and Sweden, 
Vasolipid®).
Figure 1
Particle size analysis with Coulter Counter TA II, 50 µ m aperture. The 
results are expressed as a percentage of the fat (% of total lipidic frac-
tion = TLF). Dilution 1:100,000, particle diameters 0.79 to 5.04 µ m. 
Mother emulsions (ME) containing Intralipide® 20% are at 6.83% TLF; 
those containing Medialipide® 20% are at 3.39 and 2.66% TLF.
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dilutions were studied:
(1) 1:100,000 (final lipid concentration of 2 × 10-4g/100
ml) for particles with diameters between 0.8 and 5.04 µm.
This value was then, in reference to internal laboratory val-
ues, correlated with the global granulometric state of the
emulsions.
(2) 1:1000 (final lipid concentration of 2 × 10-2g/100 ml)
for particles with diameter > 1.59µm. The acceptable limit,
for this method and this last dilution, was 0.40% of fat in the
mixture existing as particles with a diameter > 5 µm [1].
The above tests were performed at D1, D3, D7, D10, D14,
D21, D28, D28 + 24 h (D29). pH was tested at every gran-
ulometric control stage. Conformity to the formula and
osmolality was tested at the beginning and at the end of the
study. The chemical analysis performed during the study
measured the concentrations of the total nitrogen anhy-
drous glucose and glycerol, in order to confirm the each
mixture conformed to its theoretical formulae (accepted
limit ± 10%).
Results and discussion
Addition of ions, pH variation, but also lipid and amino acid
composition influence the stability of parenteral nutrition
mixtures [3,4,6,7]. The six tested mixtures were not ion-sup-
plemented. The nitrogen content and quality of the triglyc-
erides varied depending on the frequent clinical situation
for which the mixture was used. There was no microscopic
destabilization from D1 to D29 (no change in the colour or
aspect of the mixtures). The mixtures at D29 were micro-
scopically identical to the D1 mother emulsions. Analysis of
particle size distribution revealed a difference between
Intralipide® and Médialipide® in particles with diameter < 5
µm without by shift in the distribution curves (Figs 1 and 2).
Figure 2
Particle size analysis with Coulter Counter TA II, 50 mm aperture. The 
results are expressed as a percentage of the fat (% of TLF). Dilution 
1:1000, particle diameters 1.59 to 5.04 mm. Intralipide® 20%, ME = 
0.42% TLF; Medialipide® 20%, ME = 0.19 and 0.13% TLF.
Figure 3
Particle size analysis with Coulter Counter TA II, 50 µ m aperture. The 
results are expressed as a percentage of the fat (% of TLF). Dilution 
1:1000, particle diameters > 5.04 µ m. Intralipide® 20%, ME = 0.02% 
TLF; Medialipide® 20%, ME = 0.02 and 0.06% TLF.
Table 2
Theoretical and D28 + 1 values of total nitrogen, anhydrous glucose and glycerol. None of the formulae at D28 + 1 exceed theoretical values 
± 10%
Total nitrogen (g/l) Anhydrous glucose (g/l) Glycerol (g/l)
Formulae Theoretical D28 + 1 Theoretical D28 + 1 Theoretical D28 + 1
1 7.31 7.49 128.6 127.5 6.43 6.65
2 7.31 7.21 128.6 127.3 7.14 7.48
3 8.53 8.58 166.7 178.6 7.50 7.28
4 8.53 8.49 166.7 155.5 8.33 8.53
5 10.11 10.17 171.05 164.8 6.58 6.60
6 9.85 9.75 153.85 148.8 7.69 8.15Page 3 of 4
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same for Intralipide® and Médialipide® (Fig 3). In all mix-
tures, no evolution (granulometric destablization or break-
down of the emulsion) was observed over the 29 days,
regardless of the formula tested (Figs 1,2,3). All the mix-
tures conformed to the theoretical compositions, and there
was not evolution during storage (Table 2). Osmolality and
pH were not significantly different from D1 to D29 (Table
3).
Conclusion
All the stability tests complied — the six ternary unsupple-
mented controlled mixtures were stable and acceptable for
normal therapeutic use after a long storage period, ie 28
days at 4°C, plus 24 h at room temperature. Therefore the
choice of triglyceride mixture used in defined solely by the
clinical and metabolic requirements of each regimen.
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Table 3
pH at D1 and D28 +1 for the six mixtures tested
Formulae
Day 1 2 3 4 5 6
D1 6.56 6.55 6.62 6.48 6.42 6.47
D28 + 1 6.59 6.56 6.59 6.57 6.51 6.58
